Smokers pay tens of thousands more for life insurance and mortgage protection
Smokers pay tens of thousands of euro more for life insurance and mortgage protection than non-smokers, according to new research from price comparison and switching website
bonkers.ie
.
For mortgage protection – a legal requirement for anyone taking out a mortgage in Ireland – a 38-year-old couple can pay as little as €35.60 a month for €300,000 in cover over 30 years as long as they're both non-smokers.
However, if they both smoke, the cost jumps to €70.09 – an increase of almost 97 per cent, or nearly €12,500 over the life of the policy.
Adding €100,000 in specified illness cover to the same policy would cost €101.09 a month for non-smokers. But smokers would pay at least €191.82, a difference of almost €33,000 over the term.
READ MORE
The gap is even wider for life cover which pays out a tax-free lump sum if one of the insured dies during the term of the policy and is considered an essential part of financial planning for families.
A non-smoking couple could secure €300,000 in cover over 30 years for about €51 a month, while smokers would pay at least €103.88 – a difference of almost 103 per cent, or almost €19,000 over the lifetime of the policy.
And for a stand-alone specified illness policy worth €150,000 over 30 years, non-smokers would pay €195.87 a month, while smokers would be charged €333.44 – almost €50,000 extra for the same level of cover.
The research was carried out in May by comparing prices for smokers and non-smokers from the country's five leading life insurers: Aviva, Irish Life, New Ireland, Royal London Ireland, and Zurich Life.
While smoking has declined in recent decades, about 16 per cent of adults aged 15 and over in Ireland still smoke either daily or occasionally, according to Census 2022. However, many more vape – and vapers, even if they've never smoked in their life, will still be treated as smokers by life insurers.
[
Cost of health insurance rises over 12% in a year, with some policies jumping 25.6%
Opens in new window
]
'Quitting smoking really is good for your pocket as well as your health,' said Daragh Cassidy of bonkers.ie. 'It's not just the cost of cigarettes that you'll save on. As our research shows, the price you pay as a smoker for important life insurance products is often close to double what a non-smoker would pay. This means kicking the habit can literally save you tens of thousands of euro.'
He added that people who vape are also considered smokers by insurance companies.
'The good news is that if you're already paying for life cover, but decide to quit, once you've been off cigarettes, as well as any nicotine replacement products, for at least 12 months, you can apply to be reassessed as a non-smoker and potentially pay a lower price for your existing cover.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Times
44 minutes ago
- Irish Times
Should the maker of Ozempic be funding children's playgrounds in Ireland?
Last Monday Taoiseach Micheál Martin posted on social media about his delight at attending the unveiling of a primary school's new playground equipment that is 'part of Novo Nordisk Ireland's ongoing Play at Primary School Initiative'. The initiative by the manufacturer of Ozempic and Wegovy involved providing nine Deis schools with equipment, with plans to expand to more schools during 2025. On the face of it, new playground equipment seems a commendable and worthwhile initiative. But the question has to be asked: what's in it for Novo Nordisk, which has a track record in sophisticated public relations campaigning? Fundamentally, there are potential ethical considerations with any company or industry paying for children's playground equipment. But Novo Nordisk deserves additional scrutiny given its marketing practices. READ MORE In 2023, the Danish drug manufacturer was suspended by its own industry body in the UK for two years over its sponsorship of weight management courses for health professionals. This is the most severe punishment that the Association of the British Pharmaceutical Industry has issued and was only the eighth occasion in the past 40 years the ABPI board has issued such a significant sanction. It led to the Royal College of Physicians and the Royal College of General Practitioners ending their partnerships with Novo Nordisk. The suspension occurred because Novo Nordisk paid for a 'large scale Saxenda [a weight-loss drug] promotional campaign […] which was disguised' and included 'heavily biased' information. The ruling outlined 'serious concerns about Novo Nordisk's culture' and raised further concerns about Novo Nordisk at the global level. In March 2025, the ABPI voted to readmit Novo Nordisk as a full member on the basis that it 'now had the systems and culture in place' to resume self-regulation. But Novo Nordisk was since found to be in breach of UK marketing regulations on several more occasions . In Ireland, issues have also emerged. Through a freedom of information request, I obtained an inspection report by the medicines watchdog, the HPRA, of Novo Nordisk's advertising-related activities for the period January 2021 to May 2023. My findings that the pharma company broke rules around the advertising and marketing of its medication to healthcare workers over three years were reported in The Irish Times on Friday. The HPRA found 'a significant number of non-compliances' with Novo Nordisk's advertising and 'educational' activities. [ Maker of Ozempic and Wegovy broke advertising rules, regulator finds Opens in new window ] They outlined that the 'level of control and governance that was in place for educational activities, promotional and non-promotional meetings with healthcare professionals, advisory boards and medicinal product advertising were deficient'. Issues outlined included presentations to healthcare professionals that were 'unbalanced' in nature. It also found the omission of important and legally required drug information relating to adverse reactions, precautions and contraindications in materials intended for use with patients and in a promotion to healthcare professionals. A teaching guide intended for use with patients included advertising for a prescription-only product, which is not legally permitted. The HPRA also observed compliances with requirements. In response to the HPRA review, Novo Nordisk outlined a range of procedural changes. This includes extensive reviews of slides presented by third parties for work affiliated to Novo Nordisk; the removal of materials in breach of regulations; updates to internal guidance; and the introduction of relevant training processes. A spokeswoman told The Irish Times that the company 'addressed the findings to ensure compliance with industry regulation and this was completed to the HPRA's satisfaction immediately following the inspection' and that its focus 'remains on meeting the needs of patients, healthcare professionals and partners'. Between 2016 and 2023, Novo Nordisk has reported making payments valued at over €6.6 million to healthcare organisations, a patient organisation and healthcare professionals, based on my analysis of Novo Nordisk's disclosures on – the pharmaceutical industry's record of direct or indirect financial support or 'transfers of value' to healthcare professionals – and the disclosures of patient organisation payments Novo Nordisk makes on its website. It's not clear whether this is the full picture: research I was involved with has highlighted significant shortcomings with the Irish payment declaration system. In the UK, Novo Nordisk has been found to be underreporting payments to the value of almost £8 million (€9.5 million) to 150 doctors, patients, journalists and healthcare organisations. One might ask why €6.6 million in payments to individuals and organisations in our health system would be problematic? The pharmaceutical industry describes these payments as being for education, research and healthcare. But payments such as these have well-recorded effects on prescribing practices, and are linked to recipient organisations favouring the positions of the funder. Novo Nordisk has made payments to help set up patient organisations, to pay senior decision makers in the Irish health system consultancy fees, and to help fund clinical guidelines on obesity in Ireland. Guidelines and patient organisations are important endeavours, but there are valid concerns about industry funding, as international evidence shows that it can influence important organisations and initiatives. When it comes to Novo Nordisk paying senior health system decision makers as consultants, significant scrutiny is necessary given the influence they have over our health system. Nothing here is intended to question the benefits of Novo Nordisk's approved medicines – if a medicine is approved for use in Ireland then the evidence shows that it meets the required standards for benefits and risk. What we should question is whether the drug maker's marketing efforts are affecting the decision making of our politicians, policymakers, prescribers and healthcare organisations. These decisions should be based on evidence only, not who has paid for our playgrounds, our conferences or our lunches. Novo Nordisk is applying to the State to reimburse its weight loss drugs for a much larger group of people. This decision has the potential to put unprecedented pressure on the State's health budget, potentially more than doubling state expenditure on medicines to €10 billion. The drugs are so expensive that US researchers have suggested it would be less expensive for the United States to just buy Novo Nordisk than to reimburse its weight loss drugs. There's a reason that the College of Psychiatrists of Ireland ended pharmaceutical industry partnerships in 2010 and the Irish College of General Practitioners last year voted to phase out pharmaceutical industry partnerships. It's because, as the College of Psychiatrists put it, the college's aims do not always align with the industry's aims and there is a need for the college to be able to provide 'independent appraisal of the value of specific drugs'. Our health and education systems struggle for funding for important initiatives. Pharmaceutical companies and other industries sometimes step into this void. But we need to ask if there are hidden costs to this funding, costs that may not be worth paying for. James Larkin is a senior postdoctoral fellow in the department of General Practice at RCSI
Irish Times
an hour ago
- Irish Times
Ireland cannot base its economic strategy on the ‘Taco' theory – Trump Always Chickens Out
The Trump tariff story rolls on and on. Even over the past week or so, we have had threats of 50 per cent tariffs on the EU to apply from this weekend, then a postponement of this deadline till July , then a court ruling that the US president did not have the authority to impose such blanket tariffs at all, followed by an appeal court decision which put a stay on this decision. Confused? Well, join the club. Even the finest legal and political minds are struggling to keep up and identify where, exactly, we are now and what might happen next. The financial markets have been operating on the basis of what has been dubbed the 'Taco trade' – with analysts arguing that investors should keep buying shares because 'Trump always chickens out' on his tariff threats. We can hope this continues and that the worst does not happen. But it would be most unwise to base Ireland's economic strategy on the Taco theory and the hope that all the transatlantic trouble will be sorted quickly. Donald Trump could as easily lash out as chicken out. We just don't know. The odds are that the rocky period we are now seeing is not going to end any time soon. Trump's talk of doing strings of trade 'deals' is based more on Maga promo than reality, judging by the flimsy details which have emerged to date. Treasury secretary Scott Bessent's comment late on Thursday that talks with China are 'stalled' is also significant. READ MORE And the negotiations with the EU do not seem to have made much progress, as a Brussels hierarchy driven by process meets the chaos of Washington. Smarter minds in Dublin worry that the EU may be in a dangerous place, being late in the queue of countries trying to reach some kind of accommodation with Trump. The extent to which Trump can use his tariffs weapons is now in question, after the federal trade court decision that he exceeded his powers with blanket tariffs. But he will appeal – and still has the legal option to use tariffs in specific sectors on national security grounds, like tech and, important for Ireland, pharma . His new budget bill also gives the US the power to target companies and individuals from countries seen to treat US companies unfairly with penal extra taxes. Tax wars could yet join trade wars. So where does this leave Ireland? The Government cannot be hypnotised into inaction by the White House and the risks from what Trump does next. It needs to be seen to get on with it and send out a message that it is going about its business amid the international chaos. And here the next couple of months will be crucial. A review of Ireland's massive State investment plan – the National Development Programme (NDP) – is due for publication over the summer. So is the so-called Summer Economic Strategy, which sets out the game plan for the Budget. After a shaky start, the Coalition needs to use these to try to shape a new narrative. The Government can't remove the uncertainty that has spread through the economy and is now stalling investment and, increasingly, hiring. But it can try to underpin confidence by focusing on doing a few important things. One is approaching the budget in a sane and strategic way – unlike last year's pre-election giveaway – and building Ireland's leeway for a possible hit to corporate tax revenues and what seems now an inevitable general economic slowdown. [ Truth Social diplomacy, a shock court ruling and fashion magnate advice: A week inside the EU-US tariff talks Opens in new window ] This will require a summer battle between the budget ministers Paschal Donohoe and Jack Chambers and the rest of the Cabinet, who will see extra billions and want to spend them. And, for now, extra billions are indeed likely. Ireland's growth figures, and quite possibly corporate tax revenues, are about to get another boost from huge exports to the US so far this year, as pharma and other sectors try to get product across the Atlantic there before tariffs hit. On paper, Ireland's economic boom is about to get boomier. In reality, this is a classic once-off boost which will reverse, sooner rather than later. The other key challenge for Ministers is to start to get to grips with the big infrastructural blockages facing the economy and building some kind of positive narrative, rather than continued talk of failure and a seeming inability to progress anything. This is now urgent. Big US investors here have projects on hold due to the tariff uncertainty. Sooner or later they will have to make a call on where to invest next. Ireland cannot control the impact of whatever Trump does on these decisions. But the State's infrastructural shortcomings are now a big factor in what they do next and here the mood music is poor. This will take years to fix, but the Government needs to get out the message that it has a plan and, crucially, that it can execute it. Of course, it also has to cope as best it can with swings of the Trump-driven agenda. The ongoing exceptionalism of Irish economic data – set to repeat this year – unfortunately keeps the State in the spotlight. There will be tricky territory to negotiate as the focus intensifies on the extent of pharma exports by US companies from their Irish bases to the American market – a big factor in the US trade deficit with the EU – and the tax boost Ireland gets from this, at the expense of Uncle Sam. And as the OECD corporate tax deal, which Ireland hoped would lead to some peace in this area, gradually falls apart, putting a lot back into play in another vital area for Ireland. [ Donald Trump's tariffs setback: the president's policies continue to unravel Opens in new window ] In turbulent times, you always look for the pressure points. Pharma and corporate tax are the key ones for Ireland. But it also has some economic and budgetary strengths to help in trying to pick a way through all this. Relying on a 'Taco' strategy and hoping the transatlantic threat falls away in the months ahead looks unrealistic. But the Government cannot just sit back and be hypnotised by what is happening in the White House – it needs to be seen to get on with it.
Irish Times
an hour ago
- Irish Times
Ruby Eastwood: Why would anyone choose to live in a city as ridiculous as Dublin?
You hear stories about how people survive in this impossibly expensive city. Couples who stay in loveless relationships because they can't afford to separate. Strangers from Facebook groups sleeping in the same room. A bed rented by one person in the day and a different person at night. Tenants paying their landlords with sex . Artists squatting illegally in their studios. People sleeping in storage units. These stories are full of human ingenuity and degradation. They're really quite strange when you think about them properly. The strangest part is how common they've become. [ Ireland's rising rents: 'Our budget would have been €1,300 a month, there isn't even anything listed for that' Opens in new window ] About a year ago, my best friend in Dublin moved to Berlin , where he says it's still possible to be broke and live well. When he left his damp, windowless room near Connolly Station – which cost just under a thousand euros a month – there were people queuing for the privilege of being next. Now he lives in a sunlit attic for a fraction of the price, and drinks Fritz Colas and Berliner Pilsners on the rooftop. Every so often, during our calls, he tries to convince me to join him. His logic is hard to fault: Dublin is untenable. Unless you have private wealth or can stomach a corporate job, you resign yourself to chronic financial dread – the kind that squats over your life like Fuseli's goblin in the painting. At least in other expensive cities, such as New York or London, you can escape your overpriced room into a pulsing metropolis, with endless distractions and some of them free. In Dublin, all you can really do is go to the pub, and even that costs too much. The city is very small, and it seems to constrict as the years pass. You can't leave the house without seeing a face you know. In fact, there are no faces you don't know. They approach from all sides. And the rain. The constant rain. I recognise the truth in this, and it's hard to argue with. Why would anyone choose to live in such a ridiculous city? I don't know if I really understand my own reasons for staying. I suspect they're quite shameful: they have more to do with a romantic or aesthetic impulse than with anything practical. READ MORE I just like Dublin. I like the harsh beaches and the Martello towers. The silvery, rinsed-out light. I like walking through the sprawling industrial wastelands on the city's fringes. I like the canals in spring, all fragrant with weeds and strewn with sunk bicycles. Strangers here seem to want to tell you things – like the old lady who, for no discernible reason, wanted to talk about the time she heard Bob Marley singing Redemption Song at Dalymount Park. You witness things. Once, on Talbot Street, I saw a man with an arm in a cast get into a physical fight with a man on crutches. I like Dublin on the rare occasions when it snows. I like the hot, malty smell from the Guinness factory. I like the Liberties, where you can hear the quiet rush of subterranean rivers, and church bells, and horses' hooves. I like that ugly statue of Oscar Wilde with the pervert's smile. I even like the loud, sentimental music on Grafton Street, and the whiskey-soaked ballads streaming from the pubs in Temple Bar. The idea of leaving Dublin becomes more, not less, appealing as I become more entrenched here ... we can weather all sorts of adversity, but banal contentment is the real deadener Mainly, though, I like Dublin because I chose it. The first time I visited, I was 21. I had some half-baked but very attractive notion of what Ireland represented: something to do with resistance, with migration and nostalgia and alcoholism. I had a copy of Finnegans Wake and I think I got about three pages in on the bus ride into town before falling asleep. When I woke up, I scrambled off and left the book behind. I had oysters for lunch that day and pictured my whole life in the city. It felt just the right size to make mine. I've lived in bigger cities: Barcelona, where I grew up, and London, where I lived before coming here; and smaller, random places: Brighton, Siena. I've spoken to quite a few Dubliners who are desperate to move to other European cities and can't understand my decision to stay. There's a kind of faith involved in choosing a city. You respond to its atmosphere, its pace and texture, the way it opens up to you – or doesn't. Dublin, for all its flaws, felt like it might yield something if I stayed long enough. The beginning in a new place is always the hardest part: slow, bitty, full of doubts. I didn't know anyone. I'd been accepted into a master's programme but couldn't fund it and had to defer my place by a year. When my sublet ended, I had to return to London for a while because I couldn't find another room. I worked in bars and signed up with a temp agency that sent me on scattershot catering shifts around the city. The jobs were mostly tedious, but they offered a kind of education. I learned how the different bits of the city fit together, like a giant jigsaw. The glassy conference rooms down by the Quays. The Leopardstown racecourse, where West End men come on weekends to get extravagantly drunk. The grand Georgian hotels and restaurants, where they throw out so much good food it makes you want to cry. The methadone clinic at the end of the bus line where you hear the wildest conversations and sometimes get drawn in. [ Dublin: The 13th best city in the world ... supposedly Opens in new window ] It occurs to me that the difficulty of establishing yourself in a city confers a special kind of meaning on your relationship to it. Like in a toxic romance, if you can weather the lows, the highs are incredible. Who knows – maybe the expensiveness and impossibility of a place like Dublin, far from being deterrents, actually deepen its appeal, the way we fetishise designer handbags but never their identical fakes. I've always had this wrong-headed idea that the value of something is revealed by the sting of its attendant sacrifice. Gradually, my life in Dublin took on more solidity. I was lucky enough to receive a university grant. I met people. I signed a lease. I moved in with a friend and we painted all the walls fresh white. She bought velvet floral curtains in pastel colours and hung them in the livingroom. I found a few prints in charity shops. I got a Persian carpet from a lady in Blackrock Market. A friend gave me a desk she no longer needed. Sometimes the city sends you little signs of progress. The quiet, stoical man in the corner shop at the end of my road has started calling me 'honey', and occasionally smiles. I have a friend's spare keys on my keyring. I know the name of my neighbour's dog. I know which cobbler to go to for the best deal. Ruby Eastwood Still, there are days when I fantasise about leaving. It would be nice to buy lunch in a cafe without feeling frivolous. It would be wonderful not to feel like I'm stuck in a recurring nightmare every time rent comes around. Oddly, the idea of leaving Dublin becomes more, not less, appealing as I become more entrenched here. Maybe that's no coincidence. To return to the toxic romance analogy: we can weather all sorts of adversity, but banal contentment is the real deadener. Recently, I spoke to a friend in London who's moving to Iowa City for a master of fine arts degree. He told me he's spent hours on Google Maps, exploring the place through Street View. The images all seem to have been captured on sunny days – it looks green and beautiful, full of classic American wood-frame houses. He's begun to associate the town with Iowa Dream by Arthur Russell, all melodic guitar lines and soft lyrics. The self he pictured living there was different from the one he knows in London: less anxious, more social, content to spend long afternoons drifting around and hanging out with friends. [ Trevor White: I love Dublin. But there's no point in pretending it's a great small city Opens in new window ] I also indulge in this kind of cartographic dreaming. I explore prospective cities on Street View: Beirut, Paris, Berlin. It's a surreal activity. You pick a spot on the map and drag yourself along, imagining a parallel life. Sometimes, from one click to the next, the sun disappears and rain slicks the tarmac. Figures with blurred faces vanish or are replaced by others in different clothes further down the road. You realise the map is stitched together from footage taken on different days, in different moods. Another thing my friend hinted at stayed with me: that emigration can be indistinguishable from escapism. When I imagine myself in another city, I don't picture myself as I am now, but a physically and intellectually tweaked version. In Paris, I'm gaunt with a perfect bob; I smoke straights and read Lacan for pleasure. In Beirut, I am somehow fluent in Arabic; I drink less; I am sharper and more spiritual. I study ancient manuscripts. In Berlin, I am reunited with my best friend and we live together like Robert Mapplethorpe and Patti Smith before it all fell apart, looking cool and making great art. The fantasy isn't really about the new city. It's about becoming a new person. [ Emer McLysaght: Five lessons Dublin can learn from Zurich Opens in new window ] There's a way of reading this that feels a little bleak. You could say it reflects a kind of ambient self-disgust, or an inability to accept life as it is. A symptom of being stuck in the wheel of samsara: trapped in a cycle of craving and disappointment, forever projecting some improved self just over the horizon, never quite admitting that the old self follows you everywhere. There's truth in that, but it's not the whole story. There's another, more generous way to see it. Maybe it isn't escapism, but a kind of unconscious recognition that we are always in the process of becoming. Cities aren't just stages on which our lives play out. They are the biggest collaborators. They shape how we speak, how we move, how we think. They alter our trajectories. When you choose to stay in a place, you're submitting to its influence. To live in a city is to enter into a kind of contract. You agree to spend your time, your energy, and your labour in its service. In return, it promises transformation, but on its own terms. Like the enchanted gift in a fairy tale, the city will change you in ways you can't predict, and not all of them will be kind. The point is you don't get to choose. It's a gamble. Is it one worth taking? Ruby Eastwood is a writer living in Dublin
